Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


European Pharmaceutical Pricing & Reinbursement

29 Oct 2012 - 30 Oct 2012 - London, UK



Bookmark and Share


SMi are proud to present their 18th annual market leading European Pharmaceutical Pricing and Reimbursement conference. This year’s event will bring together experts from a range of industry perspectives to discuss solutions and strategies within key issues such as market access strategies, recent developments in the healthcare landscape and challenges in VBP and AMNOG. As well as exclusive presentations on the latest P&R developments across Europe and further afield, the event will act as a unique forum for attendees to learn, make connections and explore new ideas.

Key benefits of attending:

Hear from experts in the field on Value Based Pricing: Principles and practice

Debate EU policy challenges in access to medicines in Europe with experts from Germany, Italy, UK, Switzerland and Belgium

Analyse market access in Russia, Turkey and Eastern Europe

Learn about the latest regulations within pricing and reimbursement from industry

Understand the facts and consequences of Germany’s AMNOG

Discover the value of collaboration in HTA and managed entry schemes

Consider an international view with perspectives from the Asia-Pac Region and North America

Network with and learn from senior industry representatives from companies such as Sanofi, GSK, Abbott & UCB 

Quote “Technology Network” and save £100

Register online here: http://www.smi-online.co.uk/goto/2012europricing26.asp



Further information
Scientific News
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!